CHRISTIAN J. MORAN, Special Master.
On behalf of her daughter, A.H., Ms. Lizette Stillabower alleged that the third dose of the human papillomavirus (HPV) vaccine caused A.H. to suffer a condition known as Evans syndrome. Ms. Stillabower and A.H. testified at a hearing. Following the hearing, the undersigned issued tentative findings of fact, and Ms. Stillabower obtained a report from an immunologist, Eric Gershwin.
The Secretary has challenged the sufficiency of Dr. Gershwin's report by filing a motion for ruling on the record to which Ms. Stillabower has interposed an objection. For the reasons explained below, Dr. Gershwin's report does not advance Ms. Stillabower's case. Therefore, the Secretary's motion is GRANTED.
Ms. Stillabower filed her petition on February 23, 2017, and shortly thereafter filed medical records. The first set of materials includes, as exhibit 3, a letter from a doctor who treated A.H., Dr. Mehta. The Secretary reviewed this material and concluded that Ms. Stillabower had not established that she was entitled to compensation. Resp't's Rep., filed June 28, 2017. In his report, the Secretary noted that Ms. Stillabower averred facts about A.H. that were not supported in medical records created contemporaneously with the events alleged in the affidavit.
In response and in anticipation of a hearing, Ms. Stillabower filed additional information including affidavits, Facebook posts, and school records. The fact hearing was held on February 13, 2018, in Houston, Texas.
The undersigned issued an order tentatively finding facts on March 6, 2018.
After a status conference, Ms. Stillabower proposed obtaining a report from an expert. To assist in this process, the undersigned proposed a set of instructions for expert witnesses on June 22, 2018. These instructions became final on July 9, 2018.
Ms. Stillabower filed a report from Dr. Gershwin on August 22, 2018, which was initially labeled as exhibit 21. Dr. Gershwin's August 22, 2018 report cited more than 300 medical articles. Regardless of the number of citations, Dr. Gershwin's report appeared deficient in that Dr. Gershwin accepted assertions from Ms. Stillabower's affidavit that were not accepted in the order tentatively finding facts. In addition, Dr. Gershwin did not adequately address the timing in A.H.'s case. Order, issued Sept. 6, 2018.
Ms. Stillabower then filed a motion to strike Dr. Gershwin's August 22, 2018 report and filed a second report from him on December 6, 2018. This December 6, 2018 report is also labeled as exhibit 21 and all references in this decision to exhibit 21 are to the December 6, 2018 report. In a December 19, 2018 status conference, the Secretary maintained that Dr. Gershwin's report remained insufficient.
The Secretary filed the pending motion for a ruling on the record that Ms. Stillabower is not entitled to compensation on February 22, 2019. Ms. Stillabower responded on March 25, 2019. The motion is ready for adjudication.
A.H. was born in 2002. In the first 12 years, she experienced no health concerns relevant here. She began receiving the HPV vaccine when she was 11. The first and second doses of the HPV vaccine were given to her on August 23, 2013 and December 3, 2013, respectively. Exhibit 2 at 1. A.H. received the allegedly causal third dose of the HPV vaccine on March 12, 2014.
The tentative findings of fact filled gaps in the medical records between the vaccination on March 12, 2014 and the hospitalization on July 5, 2014. In this period, A.H. continued to maintain her normal activity level. She attended school and played with her friends. She was not excessively fatigued.
In very early July, Ms. Stillabower noticed that A.H.'s skin tone had become yellower and her eyes were also yellow. This discovery prompted Ms. Stillabower to bring her daughter for medical attention at a local emergency room. Doctors diagnosed A.H. first with autoimmune hemolytic anemia and then Evans syndrome. Exhibit 4 at 154-59, 224.
Evans syndrome is a condition in which a person has both immune thrombocytopenia and autoimmune hemolytic anemia. Exhibit 32 (Alice Norton and Irene Roberts,
Dr. Gershwin opines that the third dose of the HPV vaccine caused A.H.'s Evans syndrome. In the pending motion, the Secretary challenges his opinion.
Special masters possess discretion to decide whether an evidentiary hearing will be held. 42 U.S.C. § 300aa-12(d)(3)(B)(v) (promulgated as Vaccine Rule 8(c) & (d));
In ruling on the record, special masters use the same standards for adjudication. Petitioners must establish their cases by a preponderance of evidence. 42 U.S.C. § 300aa-13(a);
For off-Table cases, like this one, the elements are: "(1) a medical theory causally connecting the vaccination and the injury; (2) a logical sequence of cause and effect showing that the vaccination was the reason for the injury; and (3) a showing of a proximate temporal relationship between vaccination and injury."
Special masters are fact finders that use their accumulated expertise to judge the individual merits of claims.
Ms. Stillabower has failed to establish any
The third prong of
Dr. Gershwin did not set forth any proposed range. Exhibit 21 at 9-10. He states the interval from vaccination to the appearance of jaundice is "consistent from a temporal perspective."
In addition, Dr. Gershwin seems to assume that A.H. suffered problems based upon affidavits created during this litigation years after the events allegedly occurred. Exhibit 21 at 9-10. However, the undersigned did not find that the affidavits established on a more-likely-than-not basis the timeline asserted in the affidavits. Tentative Findings of Fact. Dr. Gershwin's assumption of a sequence not established by preponderant evidence makes his opinion not creditable.
The medical records are not clear about when A.H.'s began to suffer from Evans syndrome. (The date of diagnosis is not the same as the date of onset.) Thus, an opinion from the retained expert was critical to fill this gap. However, Dr. Gershwin did not present a clear opinion as to when A.H.'s Evans syndrome began.
To link the HPV vaccine with Evans syndrome, Dr. Gershwin proposes molecular mimicry. Exhibit 21 at 6. However, he offers nothing to substantiate the theory. For example, he does not show any homology between components of the HPV vaccine and body parts attacked in Evans syndrome. This omission is significant because according to an expert for the petitioners in a different case, "it was unlikely for the hepatitis B vaccine, having only a single antigen, to have sufficient similarity with both cell lines to result in molecular mimicry."
Given that Ms. Stillabower has not presented a persuasive theory causally connecting HPV vaccination and Evans syndrome (
In determining whether petitioners have established that a vaccine did cause a particular injury, the Federal Circuit has directed special masters to consider any statements from treating doctors.
Here, Ms. Stillabower has advanced a letter from a treating doctor, Dr. Mehta.
Ms. Stillabower demonstrated her concern for A.H. during the hearing in Houston, and A.H. communicated how Evans syndrome has affected her. In responding to this illness, they merit sympathy. However, special masters cannot decide cases based upon sympathy and, in this case, Dr. Gershwin's report contains gaps that he has not filled. Thus, Ms. Stillabower has not established that she is entitled to compensation.
The Clerk's Office is instructed to enter judgment in accord with this decision.